Monday, November 9, 2026 · Five AI analysts screened this index for stocks with the best shot at gaining +5% within 30 days
Neutral Normal choppiness · VIX 19.9
The index shows the signature of a sharp market-wide shakeout followed by a strong single-day rebound: most mega-cap tech and semiconductor names (NVDA, INTC, AMD, AMAT, MU, GOOG, ORCL) remain 20-60% below their 52-week highs with negative 30-day returns despite today's bounce. In contrast, healthcare, consumer discretionary, and select financials have posted genuinely sustained 5-day and 30-day gains while trading within a few percent of their highs, suggesting capital is rotating into steadier names rather than confirming a broad new uptrend.
Which of today's picks to actually take, and at what size, given what you are already holding. Each pick's own Suggested Allocation sizes it in isolation; this table applies the portfolio limits — at most 20 open positions and 60% of the portfolio committed in total. Run with --capital 25000 to see these sizes as order amounts rather than percentages.
| Rank | Stock | Action | Size | Entry → Target | Notes |
|---|---|---|---|---|---|
| #1 | VTRS | SKIP | — | $20.49 → $21.53 stop $18.67 |
Half-Kelly sizes this at 0% — the odds carry no edge worth capital. |
| #2 | NEM | SKIP | — | $125.16 → $131.49 stop $112.64 |
Half-Kelly sizes this at 0% — the odds carry no edge worth capital. |
| #3 | XYZ | SKIP | — | $88.56 → $93.06 stop $79.70 |
Half-Kelly sizes this at 0% — the odds carry no edge worth capital. |
| #4 | RCL | SKIP | — | $336.98 → $353.83 stop $307.66 |
Half-Kelly sizes this at 0% — the odds carry no edge worth capital. |
| #5 | CAH | SKIP | — | $274.29 → $288.00 stop $252.90 |
Half-Kelly sizes this at 0% — the odds carry no edge worth capital. |
Already open: HUM (to Nov 11), TJX (to Nov 11), UNH (to Nov 14), KO (to Nov 18), ULVR.L (to Nov 18), PFE (to Nov 19), ROST (to Nov 19), FAST (to Nov 20), CSX (to Nov 21), TRV (to Nov 22), SGE.L (to Nov 25), SVT.L (to Nov 25) … and 52 more. Symbols you already hold were excluded from this run's candidates rather than re-picked.
Position-sizing guidance only — half-Kelly per pick, bounded by the limits above. Not personal investment advice.
Viatris makes generic and branded medicines. The company beat expectations, raised its full-year financial guidance across every key metric, and is close to completing an acquisition that should add new growth products. The main risk is that generic drug pricing pressure could offset some of this momentum, and the stock has already rallied close to its own highs, so some good news may already be reflected in the price.
Why the AI likes it
What could go wrong
Calibrated probability: 59% (raw model estimate: 67%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Newmont is the world's largest gold-mining company. Its stock has been rising as gold prices climb, likely helped by investors seeking safety during the recent market turbulence, and its technical signals look healthy rather than overheated. The main risk is that if gold prices or safe-haven demand cool off, the stock's gains could unwind quickly.
Why the AI likes it
What could go wrong
Calibrated probability: 59% (raw model estimate: 70%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Block (formerly Square) runs payment and financial tools for businesses through Square and for consumers through Cash App. Its stock has surged recently after a strong earnings report and is outperforming the broader market, with technical signals pointing to still-healthy momentum. One thing to watch is a company director who has been selling shares nearly every week for months, and the stock could pull back if the broader market rally loses steam.
Why the AI likes it
What could go wrong
Calibrated probability: 59% (raw model estimate: 67%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Royal Caribbean runs cruise ships and just posted quarterly profit that beat its own guidance, prompting the company to raise its full-year earnings forecast and announce a deal to expand into all-inclusive resorts. The stock is still a bit below its recent high despite the good news, suggesting there could be more room to run. The main risk is that cruise demand depends on consumer spending, which could soften if the economy slows or fuel costs rise.
Why the AI likes it
What could go wrong
Calibrated probability: 59% (raw model estimate: 68%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Cardinal Health distributes medicine and medical supplies to pharmacies and hospitals. The company posted a strong earnings beat and raised its profit forecast for the year, helped by a renewed long-term supply deal with CVS. The main risk is that several top executives, including the CEO, sold large amounts of stock recently, and thin distribution margins leave little room for error.
Why the AI likes it
What could go wrong
Calibrated probability: 59% (raw model estimate: 66%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
This report identifies stocks with an AI-assessed probability of gaining +5% within 30 calendar days (target exit by December 9, 2026). Picks are ranked by how many independent AI agents agreed — more agreement means higher conviction. The guide below tells you exactly how to act on them.
Step-by-Step Action Plan
Position Sizing by Conviction Tier
Size each position according to the coloured border on its pick card. Cap your total exposure across all picks from this report at 25% of your overall trading budget.
| Agents Agreeing | What It Means | Max Allocation Per Pick |
|---|---|---|
| 5/5 | Highest conviction — all five independent analytical checks passed | Up to 10% |
| 4/5 | Very high conviction — four of five independent checks aligned | Up to 8% |
| 3/5 | High conviction — three agents independently agreed | Up to 6% |
| 2/5 | Moderate conviction — two agents independently agreed | Up to 4% |
| 1 Agent | Speculative — solo pick, admitted only at Very High confidence | Up to 2% |
The Three Exit Rules
A plain-English guide to every figure shown on each pick card — what it means, how it is calculated, and what a good or bad value looks like.
Scout scanned 503 S&P 500 constituents and short-listed 25 candidates for deep analysis by the five analysts. Here is what happened to each one.
Checks 30-day price history for every candidate before making any selection. Requires positive period return and positive 5-day momentum as mandatory gates. Ranks picks by proximity to their period high and adjusts probability based on volume. Uses news only to rule out major negative catalysts.
Searches earnings results, analyst upgrades, and revenue trends before checking price data. Requires at least one verifiable fundamental catalyst — earnings beat, analyst upgrade, or revenue acceleration — within the last 60 days. Favours stocks with strong fundamentals trading below recent highs (value entry).
Hunts for specific events within the last 21 days: FDA approvals, major contract wins, product launches, earnings surprises, or significant analyst upgrades. Requires a positive price reaction confirming the market is recognising the catalyst. Also scans for upcoming events that could drive further gains.
Maps the macroeconomic regime (risk-on / risk-off / neutral) and identifies sectors benefiting from current conditions before looking at individual stocks. Only selects stocks from macro-aligned sectors with confirmed sector tailwinds. Adjusts for interest rate sensitivity and geopolitical factors.
Reviews the final picks after all four analysts agree and actively challenges each bull thesis. Searches for bearish technical signals, negative news, insider selling, and elevated short interest that the agreeing agents may have underweighted. Produces evidence-based counter-arguments shown on each pick card.
Pure-quant analyst: no news, no narrative, only numbers. Identifies mean-reversion setups from RSI extremes (<35) with momentum turning, Bollinger squeeze breakouts, and multi-factor quant scores using RSI, MACD, OBV, short interest, and insider transaction data. Counterbalances narrative bias across the four analyst agents.